1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Multiplex Assays Market - Global Opportunity Analysis and Industry Forecast, 2014-2022

Multiplex Assays Market - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • March 2017
  • 180 pages
  • ID: 4930941
  • Format: PDF
  • By Allied Market Research


Table of Contents

Multiplex Assays Market by Type {Nucleic Acid-Based Multiplex Assays (Planar Nucleic Acid Assays and Bead-Based Nucleic Acid Assays), Protein-Based Multiplex Assays (Planar Protein Assays and Bead-Based Protein Assays)}, Product {Multiplex Assay Reagents & Consumables, Multiplex Assay Accessories & Instruments, and Multiplex Assay Software & Services}, Technology {Multiplex PCR, Multiplex Protein Microarray, and Others}, Application {Companion Diagnostics, Research & Development (Drug Development and Biomarker Discovery & Validation), Clinical Diagnostics (Cancer, Infectious Diseases, Cardiac Diseases, Autoimmune Diseases, Alzheimers Disease, and Others)}, and End User {Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceuticals & Biotechnological Companies} - Global Opportunity Analysis and Industry Forecast, 2014-2022

A multiplex assay is a procedure in which multiple analytes (proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. These assays are used to amplify multiple targets in a polymerase chain reaction (PCR) experiment and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional method, such as ELISA.

Multiplex assays are used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others. The global multiplex assays market has accounted for $3,470 million in 2015, and is estimated to reach $5,720 million by 2022, growing at a CAGR of 7.4% during the analysis period 2016-2022.

The multiplex assays market has witnessed growth owing to increase in R&D activities in pharmaceuticals for the treatment of diseases, such as cancer and Alzheimer’s. Multiplex assays are used in clinical trials as they decrease the cost of research and manual labor, and increase the efficiency of experiment and therapies.

In addition, multiplex assays are easier, faster, and automated as compared to conventional methods, thus fuels the market growth. However, high capital investment and dearth of skilled labor hamper the market growth.

The global multiplex assays market in this report is studied based on type, product, technology, application, end user, and geography. On the basis of type, it is divided into nucleic acid-based, protein-based multiplex assays, and other multiplex assays; nucleic acid-based and protein-based multiplex assays segment is further bifurcated into planar and bead-based assays. Based on product, it is classified into multiplex assay reagents & consumables, multiplex assay instruments & accessories, and multiplex assay software & services.

Based on technology, it is classified into multiplex PCR, multiplex protein microarray, and other technologies. Based on application, it is categorized into companion diagnostics, research & development, and clinical diagnostics.

R&D segment is further bifurcated into drug development and biomarker discovery & validation. Clinical diagnostics segment is further subsegmented into cancer, infectious diseases, cardiac diseases, autoimmune diseases, Alzheimer’s disease, and others. On the basis of end user, it is divided into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnological companies. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC., Seegene Inc., Meso Scale Diagnostics, LLC., and Randox Laboratories Ltd. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.

Key Benefits
The study provides an in-depth analysis of the global multiplex assays market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis that is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments (product, type, technology, application, and end user) facilitates in understanding the various type of products and technology used for different applications.
Key players are profiled in this report and their strategies are analyzed thoroughly, which predicts the competitive outlook of market.

Key Market Segment

By Type
Nucleic Acid-Based Multiplex Assays
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Protein-Based Multiplex Assays
Planar Protein Assays
Bead-Based Protein Assays
Other Multiplex Assays

By Product
Multiplex Assay Reagents & Consumables
Multiplex Assay Instruments & Accessories
Multiplex Assay Software &Services

By Technology
Multiplex PCR
Multiplex Protein Microarray
Other Technologies

By Application
Companion Diagnostics
Drug Development
Biomarker Discovery and Validation
Clinical Diagnostics
Infectious Diseases
Cardiac Diseases
Autoimmune Diseases
Alzheimer’s Disease
Other Diseases

By End User
Clinical Laboratories
Research Institutes
Pharmaceuticals & Biotechnological Companies

By Region
North America
Rest of Europe
Rest of Asia-Pacific
Latin America
Middle East

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
North America Hereditary Cancer Testing Market to 2027 - Regional Analysis and Forecasts by Diagnosis Type; Technology; End User, and Country

North America Hereditary Cancer Testing Market to 2027 - Regional Analysis and Forecasts by Diagnosis Type; Technology; End User, and Country

  • $ 3000
  • October 2019

The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. This market is projected to grow at a growth rate of 11.6% from 2019-2027.The ...

Polymerase Chain Reaction (PCR) Global Market - Forecast to 2025

Polymerase Chain Reaction (PCR) Global Market - Forecast to 2025

  • $ 4950
  • November 2019

Polymerase Chain Reaction (PCR) is a novel technique which amplifies the amount of target nucleic acid in every cycle.PCR has three steps such as denaturation, annealing and extension, which are repeated ...

Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019

Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019

  • $ 2500
  • November 2019

Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019" provides an overview ...

Global Cell Based Assays Industry $ 4950 October 2019


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on